Largazin Syrup 25 mg/5 ml is an antipsychotic medication used primarily to manage symptoms of schizophrenia and other psychotic disorders. It belongs to the class of typical antipsychotics and is also utilized for its antiemetic and sedative properties.
Chlorpromazine is used to treat:
| Brand Name | Largazin |
|---|---|
| Type | Syrup |
| Weight | 25 mg/5 ml |
| Generic | Chlorpromazine Hydrochloride |
| Manufacturer | United Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Chlorpromazine works by blocking dopamine receptors in the brain, particularly D2 receptors. This antagonistic effect helps to reduce dopaminergic overactivity associated with psychotic symptoms. Chlorpromazine also has anticholinergic, antihistaminic, and alpha-adrenergic blocking effects, contributing to its broader therapeutic profile, including its sedative and antiemetic properties.
Therapeutic effects of Chlorpromazine can begin within a few days of starting treatment, particularly for sedation and antiemetic effects. However, it may take several weeks to see the full benefits in managing psychotic symptoms or mood stabilization in conditions like schizophrenia or bipolar disorder.
Chlorpromazine is well absorbed after oral administration. Peak plasma concentrations are typically reached within 2 to 4 hours. The drug undergoes significant first-pass metabolism, which can affect its bioavailability.
Chlorpromazine is primarily metabolized in the liver. Its metabolites are excreted mainly through the urine, with a smaller amount eliminated in the feces. The drug undergoes extensive metabolism before being excreted.
The dosage of Chlorpromazine varies depending on the condition being treated and the patient's response. Typical dosing guidelines include:
Dosing should be adjusted based on individual patient needs and tolerability.
Chlorpromazine is administered orally in the form of tablets or liquid. It should be taken with or without food, but consistent intake with regard to meals is recommended to maintain stable blood levels. For acute conditions, it may also be administered intramuscularly.
Common side effects of Chlorpromazine include:
Serious side effects can include extrapyramidal symptoms (such as tremors and rigidity), tardive dyskinesia, neuroleptic malignant syndrome, and severe allergic reactions.
Toxicity from Chlorpromazine may present with severe symptoms such as excessive sedation, hypotension, and anticholinergic effects. In cases of overdose, treatment involves supportive care and symptomatic management, including monitoring of vital signs and potential use of activated charcoal if ingested recently.
Precautions for using Chlorpromazine include:
Chlorpromazine can interact with several other medications, including:
Chlorpromazine should be used with caution in patients with:
Drug interactions may include:
There are no significant food interactions with Chlorpromazine. However, it is advisable to maintain a consistent diet and avoid excessive alcohol consumption to minimize interactions and side effects.
Chlorpromazine is classified as Category C for pregnancy, indicating that risk to the fetus cannot be ruled out. It should be used during pregnancy only if the benefits outweigh the risks. Consult with a healthcare provider before using Chlorpromazine during pregnancy.
Chlorpromazine is excreted in breast milk, and its use during lactation is generally not recommended. The potential for adverse effects on a nursing infant should be considered, and alternative treatments should be discussed with a healthcare provider.
Acute overdose with Chlorpromazine can cause severe sedation, hypotension, and anticholinergic effects. Immediate medical attention is required. Treatment involves supportive care, monitoring of vital signs, and symptomatic management.
Chlorpromazine is contraindicated in individuals with:
Chlorpromazine should be taken as directed by a healthcare provider. Adhere to prescribed dosages and administration schedules. Regular monitoring by a healthcare provider is recommended to adjust doses and manage side effects.
Store Chlorpromazine at room temperature, away from moisture and direct sunlight. Keep the medication in its original container, tightly closed, and out of reach of children.
The volume of distribution for Chlorpromazine is approximately 16 to 20 liters per kilogram, indicating that it is widely distributed throughout the body tissues, including the central nervous system.
The half-life of Chlorpromazine is approximately 30 to 60 hours, which means it remains in the body for an extended period and influences dosing intervals.
Chlorpromazine is primarily cleared from the body through hepatic metabolism. The clearance rate can be affected by liver function and potential interactions with other medications. Monitoring and dose adjustments may be required for individuals with liver impairment.
See in details version Largazin Syrup 25 mg/5 ml also Largazin Syrup 25 mg/5 ml in bangla